PTSD screening among serving RCMP respondents
[1] Carleton et al. (2024), original study (opens in a new tab)NPF report, Table 4 (opens in a new tab)
OUR APPROACH
Understand the need, explore the research and see how Project Life Spark hopes to contribute to Canadian evidence.
THE NEED, IN CONTEXT
[1] Carleton et al. (2024), original study (opens in a new tab)NPF report, Table 4 (opens in a new tab)
[2] Nisbet et al. (2024), CIMVHR abstract 2E03 (opens in a new tab)NPF report, Table 3 (opens in a new tab)
Carleton et al. (2024) (opens in a new tab)NPF report, Table 4 (opens in a new tab)
[4] Total from National Defence, 2023 report, Tables 5 and 9 (opens in a new tab)
Firefighters and paramedics also belong in this conversation. Canada's National Suicide Prevention Action Plan (opens in a new tab) identifies public safety personnel as a priority population. These findings help explain the need for support; they do not describe every person’s experience.
EXTERNAL TREATMENT RESEARCH
These studies examined different treatments and populations. They are not Project Life Spark results or promises about an individual's care.
In a small randomized pilot study, 10 of 12 participants receiving MDMA-assisted psychotherapy no longer met PTSD diagnostic criteria at the two-month endpoint, compared with 2 of 8 receiving psychotherapy with placebo.
[5] Mithoefer et al. (2011), original study; first published online in 2010 (opens in a new tab)A 2024 uncontrolled observational study of 30 male US Special Operations veterans with predominantly mild traumatic brain injury reported an average 88% reduction in PTSD symptoms one month after treatment.
[6] Cherian et al. (2024), Nature Medicine (opens in a new tab)Stanford’s explanation of the 88% figure (opens in a new tab)In a retrospective survey of 51 US Special Operations veterans, 96% rated a treatment program in Mexico as much better than treatments they had previously tried.
[7] Davis et al. (2020), original study (opens in a new tab)These figures describe specific historical studies, not a complete review of the evidence or a statement of treatment approval. Clinical partners need to explain current evidence, risks, alternatives and suitability before any treatment decision.
VOLUNTARY OUTCOME TRACKING
Project Life Spark's developing initiative includes post-traumatic stress, depression, anxiety, substance use, overall wellness, and head injury or blast exposure. The full ten-measure framework and scientific-partner details are still to be confirmed with the team.
Declining future outcome tracking does not affect funding eligibility. This is separate from the clinical information needed for intake and care coordination.
Data collection is underway, while analysis, formal protocol development and research ethics review remain work to complete. This is not a completed or published Project Life Spark study.
FROM EXPERIENCE TO CANADIAN EVIDENCE
Project Life Spark's longer-term aim is to contribute Canadian data that can inform future research and healthcare discussions while supporting people now. The proposed Canadian Signal Study remains a developing initiative.
Build Canadian evidenceAsk what information is collected, who receives it, how it is handled, how consent works and what choices you have. The team should explain these details before you agree.
Ask about the data initiative